UncategorizedNovo Nordisk shares pop 9% on early-stage weight loss drug trial results Blaze Burgess1 month ago01 mins The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug. Post navigation Previous: António Guterres calls on M23 rebel group to cease offensive in DRCNext: Ukraine Sends Volley of Drones at Russia, Hitting Oil Refinery
Deepseek’s AI model is ‘the best work’ out of China but the hype is ‘exaggerated,’ Google Deepmind CEO says Blaze Burgess4 weeks ago 0
Thousands protest against Trump’s war on immigrants after Ice raids: ‘Fight for our neighbors’ Blaze Burgess4 weeks ago 0
Gyalo Thondup, Political Operator and Brother of the Dalai Lama, Dies at 97 Blaze Burgess4 weeks ago 0